Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential role of MLKL in alcohol-associated and non–alcohol-associated fatty liver diseases in mice and humans
Tatsunori Miyata, Xiaoqin Wu, Xiude Fan, et al.
JCI Insight (2021) Vol. 6, Iss. 4
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease
Xiaoqin Wu, Xiude Fan, Tatsunori Miyata, et al.
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 411-438
Open Access | Times Cited: 146
Mediators of necroptosis: from cell death to metabolic regulation
Xiaoqin Wu, Laura E. Nagy, Jérémie Gautheron
EMBO Molecular Medicine (2024) Vol. 16, Iss. 2, pp. 219-237
Open Access | Times Cited: 20
Gasdermin and MLKL necrotic cell death effectors: Signaling and diseases
Kate E. Lawlor, James M. Murphy, James E. Vince
Immunity (2024) Vol. 57, Iss. 3, pp. 429-445
Closed Access | Times Cited: 20
CD47-SIRPα axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis
Hongxue Shi, Xiaobo Wang, Fang Li, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 672
Open Access | Times Cited: 45
Roles of necroptosis in alcoholic liver disease and hepatic pathogenesis
Ying Zhou, Ruoman Wu, Xinqi Wang, et al.
Cell Proliferation (2022) Vol. 55, Iss. 3
Open Access | Times Cited: 41
Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation
Ren Guo, Xiaohui Jia, Zhen–Bin Ding, et al.
Theranostics (2022) Vol. 12, Iss. 11, pp. 5220-5236
Open Access | Times Cited: 41
An Update on Animal Models of Alcohol-Associated Liver Disease
Peng Cao, Xiaojuan Chao, Hong‐Min Ni, et al.
American Journal Of Pathology (2025)
Closed Access | Times Cited: 1
Senolytic treatment reduces cell senescence and necroptosis in Sod1 knockout mice that is associated with reduced inflammation and hepatocellular carcinoma
Nidheesh Thadathil, Ramasamy Selvarani, Sabira Mohammed, et al.
Aging Cell (2022) Vol. 21, Iss. 8
Open Access | Times Cited: 32
From (Tool)Bench to Bedside: The Potential of Necroptosis Inhibitors
Christopher R. Gardner, Katherine A. Davies, Ying Zhang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2361-2385
Open Access | Times Cited: 22
MLKL signaling regulates macrophage polarization in acute pancreatitis through CXCL10
Cheng Peng, Guangping Tu, Jiale Wang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 20
Absence of Either Ripk3 or Mlkl Reduces Incidence of Hepatocellular Carcinoma Independent of Liver Fibrosis
Sabira Mohammed, Nidheesh Thadathil, Phoebe Ohene-Marfo, et al.
Molecular Cancer Research (2023) Vol. 21, Iss. 9, pp. 933-946
Open Access | Times Cited: 16
An integrated network pharmacology approach reveals that Ampelopsis grossedentata improves alcoholic liver disease via TLR4/NF-κB/MLKL pathway
Ping Qiu, Ai Mi, Chunlan Hong, et al.
Phytomedicine (2024) Vol. 132, pp. 155658-155658
Closed Access | Times Cited: 7
Necroptosis contributes to non-alcoholic fatty liver disease pathoetiology with promising diagnostic and therapeutic functions
Hong-Ju Sun, Bo Jiao, Yan Wang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 14, pp. 1968-1981
Open Access | Times Cited: 5
The role of MLKL in Hepatic Ischemia-Reperfusion Injury of Alcoholic Steatotic Livers
Hao Chen, Tara McKeen, Xiaojuan Chao, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 3, pp. 1096-1106
Open Access | Times Cited: 19
Non-Necroptotic Roles of MLKL in Diet-Induced Obesity, Liver Pathology, and Insulin Sensitivity: Insights from a High-Fat, High-Fructose, High-Cholesterol Diet Mouse Model
Phoebe Ohene-Marfo, Hoang Van M. Nguyen, Sabira Mohammed, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2813-2813
Open Access | Times Cited: 4
Cell Death in Liver Disease and Liver Surgery
Christian Stoess, Yeon‐Kyung Choi, Janset Onyuru, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 559-559
Open Access | Times Cited: 4
Impact of Mlkl or Ripk3 deletion on age-associated liver inflammation, metabolic health, and lifespan
Sabira Mohammed, Phoebe Ohene-Marfo, Chao Jiang, et al.
GeroScience (2025)
Open Access
Life-threatening risk factors contribute to the development of diseases with the highest mortality through the induction of regulated necrotic cell death
Zsuzsa Muszka, Viktória Jenei, Rebeka Mácsik, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Mincle-GSDMD-mediated release of IL-1β small extracellular vesicles from hepatic macrophages in ethanol-induced liver injury
Quanri Zhang, Weiwei Liu, Katarzyna Bulek, et al.
Hepatology Communications (2023) Vol. 7, Iss. 5
Open Access | Times Cited: 9
MLKL deficiency alleviates acute alcoholic liver injury via inhibition of NLRP3 inflammasome
Yue Shen, Dongliang Chen, Min Linghu, et al.
Toxicology (2024) Vol. 506, pp. 153864-153864
Open Access | Times Cited: 3
The Role of the Key Effector of Necroptotic Cell Death, MLKL, in Mouse Models of Disease
Emma C. Tovey Crutchfield, Sarah E. Garnish, Joanne M. Hildebrand
Biomolecules (2021) Vol. 11, Iss. 6, pp. 803-803
Open Access | Times Cited: 21
Distinct Types of Cell Death and Implications in Liver Diseases: An Overview of Mechanisms and Application
Yukun Wang, Chunxia Shi, Jin Guo, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 8
Natural History of Alcohol-Associated Liver Disease: Understanding the Changing Landscape of Pathophysiology and Patient Care
Jasmohan S. Bajaj, Laura E. Nagy
Gastroenterology (2022) Vol. 163, Iss. 4, pp. 840-851
Open Access | Times Cited: 11
Derlin-1 promotes diet-induced non-alcoholic fatty liver disease via increasing RIPK3-mediated necroptosis
Ting Wang, Dehua Wang, Ge Kuang, et al.
Free Radical Biology and Medicine (2024) Vol. 217, pp. 29-47
Closed Access | Times Cited: 2
Molecular mechanisms of hepatic lipid metabolism disorders: Focus on mitochondrial quality control
Jiachi Yu, Jia Huang, Tian Xia, et al.
Portal hypertension & cirrhosis (2024)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top